DHL Global Forwarding has recertified its airfreight station in Philadelphia according to IATA’s CEIV Pharma standard.

Said David Goldberg, CEO, DHL Global Forwarding US: “A resilient and highly efficient transport network, tailored to the specific needs of the Life Sciences and Health Care industry, has never been more crucial than today.

“Therefore, we are delighted to have received not only the re-certification for IATA CEIV Pharma on a corporate level, but also for our state of the art air freight station in Philadelphia at the Philadelphia International Airport.”

The re-certification comes on the heels of a number of services and products put in place to add additional capabilities and technology to the Americas network for the life sciences and healthcare sector. They include:

  • $1.6 million investment in a brand-new Indianapolis facility
  • $650,000 investment in our San Juan, Puerto Rico, facility to add additional capabilities and technology to our Americas network for the life sciences and healthcare sector.
  • new MMEX which offers routing options from China to destination in the U.S. and Latin America with reduced transit time and cost savings.
  • LCL Expedited, an upgraded service, which offers a faster “LCL Service” by using expedited trucking as well as faster sailings on certain trade lanes to provide faster transit times for customers.
  • Dedicated flight operation with 3 x weekly roundtrips from Chicago to Shanghai to Chicago and 6 x weekly roundtrips to and from EU to China.
  • 27+ dedicated charters (globally) to help customers specifically focused on LSH shipments
  • Additional, dedicated capacity from Europe to LATAM via the DHL Global Forwarding Miami hub.
  • A Chicago / Shanghai flight (3 times a week) where DHL Global Forwarding added a stopover in Incheon so that customers in both markets could be serviced. The extended the flight operation until April 2021. 

Nina Heinz, Global Head of Network & Quality, Temperature Management Solutions at DHL Global Forwarding added: “For years, the number of regulations and requirements has been steadily increased in the life sciences and healthcare industry in general, especially regarding product transportation and storage.

“Although we at DHL have been a leader in ideas and innovation in the industry for a long time, we recognize that there is always room to improve.

“With our renewed IATA CEIV Pharma Certification, we are both clearly demonstrating our continued emphasis on constantly enhancing our service quality and showcasing that we are a reliable partner for transporting vital and temperature-sensitive products.”